Syngene

Rediff.com » News » Syngene

News for Syngene

News
Business

'No preparedness planning, no accountability, no action plan'

'This government did not have any plan for safety stocks of essential medicines.' IMAGE: Doctors attend to a patient suffering from COVID-19 inside the emergency room at the Safdarjung Hospital in......

Govt waives import duty on Remdesivir

Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......

3 lakh remdesivir to be produced daily in 15 days: Govt

The government plans to double the production of antiviral drug remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19.......

'Expect formulations biz to outpace API biz'

'API prices are dragging down margins and impacting our competitive ability.' Photograph: Kind courtesy Biocon Biocon delves into the evolving dynamics of the biosimilar market, with a focus on......

'The formulations business been a growth driver'

'Fundamentally, we think that in the coming quarters, API business should come back.' Photograph: Kind courtesy Biocon Biocon is preparing to make the most of the peptides opportunity as these......

Despite signs of fatigue, market breadth shows bulls have upper hand

The previous two sessions have seen benchmark indices, the BSE Sensex and Nifty presenting signs of fatigue, reaching closer to its all-time highs level. Both indices are down approximately 1 per......

BSE Smallcap index hits record high; experts see more upside

The S&P BSE Smallcap index hit a record high 31,396.64, gaining nearly 1 per cent on the BSE in intra-day trade on June 7 after a strong rally in railway, auto and hospitals stocks. Illustration:......

How Biocon plans to fight COVID-19

'I cannot cope with the demand. It will take us a couple of months to ramp up production.' Bio-pharmaceutical company Biocon, which saw a decline in its profit in Q1FY21 despite a double digit......

Rediff News

Syngene

News for Syngene

'No preparedness planning, no accountability, no action plan'

Govt waives import duty on Remdesivir

3 lakh remdesivir to be produced daily in 15 days: Govt

'Expect formulations biz to outpace API biz'

'The formulations business been a growth driver'

Despite signs of fatigue, market breadth shows bulls have upper hand

BSE Smallcap index hits record high; experts see more upside

How Biocon plans to fight COVID-19

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS